中恒集团：“老字号”焕发新活力

Core Viewpoint - Guangxi Wuzhou Zhongheng Group Co., Ltd. has successfully transformed from a traditional pharmaceutical company to a technology-driven enterprise during the "14th Five-Year Plan" period, focusing on innovation and research and development in traditional Chinese medicine and chemical drugs [1][2]. Innovation in Pharmaceuticals - Zhongheng Group has made significant strides in innovative drugs, particularly with the "Sanqi Granules," which received clinical trial approval from the National Medical Products Administration, targeting chronic kidney disease [2][3]. - The market for chronic kidney disease in China is substantial, with approximately 150 million patients and a market size exceeding 32 billion yuan, indicating a significant opportunity for the company [2]. Product Development and Brand Value - The company has been actively involved in the secondary development of core products, with the "Zhonghua Die Da Wan" being recognized as one of the "China's 500 Most Valuable Brands," valued at over 10 billion yuan [3]. - Zhongheng Group is expanding into cardiovascular disease treatments, with a new innovative drug targeting chronic heart failure, addressing a market with over 12 million patients in China [3]. Research and Development Investment - From 2021 to 2024, Zhongheng Group invested nearly 687 million yuan in R&D, accounting for 6.11% of its revenue, establishing a robust research funding mechanism [5]. - The company has formed partnerships with national key laboratories and universities to enhance its research capabilities and facilitate the transition from research to industry [5]. Smart Manufacturing and Technology Integration - Zhongheng Group has integrated modern technology into its manufacturing processes, significantly improving production efficiency, with the solid preparation workshop achieving a production rate of 1,000 pills per minute [6]. - The company holds 343 valid patents and has received multiple awards for its innovations, showcasing its commitment to modernizing traditional practices [6]. Brand Expansion and Market Reach - The company has successfully modernized its product offerings, such as the "Guilinggao," which has evolved from a traditional dessert to a health food product, now available in various convenient packaging [7][8]. - Zhongheng Group's brands have entered high-end retail markets and expanded online, contributing to a combined brand value exceeding 40 billion yuan during the "14th Five-Year Plan" [9].